10.24376/rd.sgul.7398596.v2
Angela Loyse
Angela
Loyse
Aude Sturny Leclere
Aude
Sturny Leclere
Timothée Boyer-chammard
Timothée
Boyer-chammard
Sarah Burton
Sarah
Burton
Tom Harrison
Tom
Harrison
Angela Loyse
Angela
Loyse
DREAMM Clinical Training: HIV–associated Cryptococcal Meningitis
figshare
2018
AIDS
Cryptococcus neoformans
global health
Clinical training
meningitis
HIV Antiretroviral Therapy
Capacity Building in the field of Higher Education
Fungal infections
Tanzania
Malawi
Cameroon
CNS infections
Rapid Diagnostic Test
LMICs
PLHIV
Healthcare workers
Public Health Data
EDCTP
ANRS
Infectious Diseases
Health Care
Medicine, Nursing and Health Curriculum and Pedagogy
2018-12-03 09:16:18
Educational resource
https://figshare.com/articles/educational_resource/DREAMM_Clinical_Training_HIV_associated_Cryptococcal_Meningitis/7398596
<div>The DREAMM education programme and all related training materials are intended for health care workers (HCWs) based/working in low and middle income countries (LMICs) across Africa. <br></div><div><br></div><div>The DREAMM education programme aims to increase the knowledge of HCWs to effectively diagnose and treat symptomatic people living with HIV (PLHIV) who present with symptoms and signs compatible with a diagnosis of meningo-encephalitis.</div><div><br></div><div>This module and supporting posters and workshops focus on HIV-associated cryptococcal meningitis, a leading cause of HIV-related meningo-encephalitis in many LMICs and is estimated to make up to 20% of HIV-related deaths in LMICs.</div><div><br></div><div>The cryptococcal meningitis training module consists of 7 sections (it is recommend to view sequentially):</div><div><br></div><div>- The impact of HIV-associated cryptococcal meningitis on health<br>- The pathophysiology of HIV-associated cryptococcal meningitis<br>- Signs and symptoms of HIV-associated cryptococcal meningitis <br>- Diagnosing HIV-associated cryptococcal meningitis <br>- Treatment of HIV-associated cryptococcal meningitis <br>- Managing HIV-associated cryptococcal meningitis: monitoring and complications<br>- Further management of cryptococcal meningitis: raised intracranial pressure, ART initiation and significant drug interactions</div><div> <br>There are three HIV-associated cryptococcal meningitis training workshops:</div><div><br></div><div>- Cryptococcal Antigen (CrAg) Lateral Flow Assay (LFA) Test – Diagnosing Cryptococcal Meningitis<br>- Safe Administration of Amphotericin B deoxycholate – Treating Cryptococcal Meningitis <br>- Safe Administration of Flucytosine and Fluconazole – Treating Cryptococcal Meningitis <br><br>The HIV-associated cryptococcal meningitis training posters are titled:</div><div><br></div><div>- HIV-associated Cryptococcal Meningitis <br>- Safe Amphotericin Deoxycholate (AmB) Administration<br>- Flucytosine (5-FC) and Fluconazole Administration for HIV-related Cryptococcal Meningitis<br>- How to perform a cryptococcal Antigen Lateral Flow Assay (CrAg LFA): IMMY CrAg<br>- How to perform a cryptococcal Antigen Lateral Flow Assay (CrAg LFA): Biosynex CryptoPS<br></div><div><br></div>